Back
American Express Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
63
AXP
American Express
Last Price:
$279.31
Seasonality Move:
6.47%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Buy
63
American Express (AXP)
is a Buy
Is American Express a Buy, Sell or Hold?
-
The current American Express [AXP] share price is $277.86. The Score for AXP is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AXP Stock Price Chart
What is American Express's stock price today?
-
The American Express share price today is $277.86The current trend is relatively stagnant and AXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
AXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.93 | Sell |
Relative Strength Index (14 RSI): | 47.7 | Sell |
Chaikin Money Flow: | 2126723 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (265.67 - 301.71) | Sell |
Bollinger Bands (100): | (278.74 - 312.18) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 71.41 | Buy |
Chaikin Money Flow: | -979016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.44 - 263) | Buy |
Bollinger Bands (100): | (240.32 - 271.8) | Buy |
AXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 267.38 | Buy |
20-day SMA: | 277.36 | Buy |
50-day SMA: | 298.26 | Sell |
200-day SMA: | 272.34 | Buy |
8-day EMA: | 270.99 | Buy |
20-day EMA: | 277.82 | Buy |
50-day EMA: | 289.16 | Sell |
200-day EMA: | 272.73 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 257.74 | Buy |
20-day SMA: | 249.75 | Buy |
50-day SMA: | 257.54 | Buy |
200-day SMA: | 251.5 | Buy |
8-day EMA: | 263.89 | Buy |
20-day EMA: | 256.08 | Buy |
50-day EMA: | 255.39 | Buy |
200-day EMA: | 243.44 | Buy |
American Express Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.08 per share, an increase this year of $1.79 per share, and an increase next year of $2.25 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
American Express Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |